Part:BBa_K3037002

dead CRISPR Associated Protein (dCas9)

dCas9
Function	Expression
Use in	Escherichia coli
RFC standard	Freiburg RFC25 standard
Backbone	pSB1C3
Experimental Backbone	pOCC97
Submitted by	Team: TU_Dresden 2019

Overview

The TU_Dresden 2019 team designed this BioBrick in order to make a fusion protein (BBa_K3037003) with dCas9 in accordance to the Freiburg RFC25 standard. (more information)

dCas9 was inserted into the pOCC97 vector (BBa_K3037000) for transformation and expression in Escherichia coli (E. coli).

There are many dCas9 BioBricks already available, however, all of them are optimized for the expression in mammalian cells. This is the very first dCas9 BioBrick that has been codon optimized for expression in E. coli. Therefore, we are adding a new scope of in vitro applications of Cas9, which is normally used in vivo, to the iGEM community.

Biology

dCas9 is a mutant derived from Cas9. Together with CRISPR, which stores sequences of viral infections, Cas9 forms a primitive antiviral defense system in bacteria. Coupled with a guideRNA, Cas9 has the ability to bind to a specific sequence of DNA and cut it. However, in contrast to its natural counterpart, dCas9 does not longer have the endonuclease activity. That means it is only binding to specific DNA sequences without cutting them. [1]

The targeted sequence is determined by the guideRNA bound to the dCas9 protein. The binding reaction was incubated at 37°C for one hour. We can put this system to use by providing guideRNAs to locate to any target DNA sequence with a high specificity.

Characterization

Overview

We performed the following characterization experiment to prove the DNA-binding ability of dCas9 via an Electrophoretic Mobility Shift Assay (EMSA) (Performed with BBa K3037005).

Experiments in Detail

1. Materials:

• 100 ng of PCR amplified sry gene
• 200 ng of dCas9-GFP
• 200 ng of guideRNA specifically targeting the amplified sry gene
• 1 x Reaction buffer - 20 mM HEPES buffer (pH 7.2)
  • 100 mM NaCl
  • 5 mM Mg{Cl{sub|2}}
  • 0.1 mM EDTA

Six different guideRNAs were designed for targeting different regions of sry gene. Using the online tool Benchling and Fasta sequence of sry gene as seen in Table 1.

1. AACTAAACATAAGAAAGTGA
2. GAAAGCCACACACTCAAGAA
3. ACTGGACAACAGGTTGTACA
4. GTAGGACAATCGGGTAACAT
5. TTCGCTGCAGAGTACCGAAG
6. CCATGAACGCATTCATCGTG

Table 1: Different guideRNAs in context with the sequence and the PAM sequence

2. Methods:

1. We wanted to check if the overall efficiency of mobility shift increases when combinations of guideRNAs were used.
2. GuideRNA, dCas9-GFP and sry gene were incubated in reaction buffer (respective amounts mentioned in the materials section) for 37 °C for 1 hour.
3. Post incubation, they were mixed with a loading dye without SDS (20 % glycerol in Orange G dye) and loaded onto 4-20 % gradient acrylamide- TBE precast gel. Gel was run for 2 and 3 hours respectively, at 75V in 1 x TBE buffer.
4. Gel was then stained using EtBR with 1:20000 dilution in 1x TBE for 10 minutes.

3. Results and Discussion Gel run for 2 h:

Figure 1 :Electrophoretic Mobility Shift Assay (EMSA) of two hours of the Cas9 with different guideRNAs

A clear sry band at 800 bp is to be seen in lane 1 of Figure 1 when the sry gene is incubated is loaded seperately. When loaded with only dCas9 in lane 2, no shift is observed in the position of the band. When guide RNA 1 was incubated with the dCas9 DNA reaction mix, we saw a shift in the mobility in lane 3. This is caused by the protein DNA interaction, where the binding is hindering the gene mobility. In the lanes 5 to 9 different combinations of guideRNAs were deployed. In the lanes 7 and 8 we see the strongest mobility shift.

From the EMSA performed above, we conclude that our expressed dCas9-GFP protein is functional and is able to successfully bind to gene with the help of appropriate guideRNAs.

Gel Run for 3 h:

Figure 2: Electrophoretic Mobility Shift Assay (EMSA) of three hours of the Cas9 with different guideRNAs

This second gel was run longer in order to get rid of all the secondary structures of the RNA formed.

From the Lanes 3 to 7 in Figure 2, no difference in the mobility of sry gene can be seen when only guideRNA is added to the reaction mix. In the Lanes 8, 9 and 10 a mobility shift of the gene can be observed and in lane 11, when only guideRNA was loaded, no bands were observed. In the Lane 12, dCas9 is in the stacking part of gel due to higher molecular weight.

4. Conclusions:

• We expressed functional dCas9, which is able to bind successfully to the sry gene with the help of our guideRNA.
• dCas9 on its own is unable to bind to the sry gene, suggesting that for binding guideRNA is required.
• GuideRNA on its own is unable to cause a mobility shift of the sry gene.

Sequence

Assembly Compatibility:

• 10
  COMPATIBLE WITH RFC[10]
• 12
  INCOMPATIBLE WITH RFC[12]

  Illegal NheI site found at 1096
  
• 21
  INCOMPATIBLE WITH RFC[21]

  Illegal BamHI site found at 3375
  
• 23
  COMPATIBLE WITH RFC[23]
• 25
  COMPATIBLE WITH RFC[25]
• 1000
  COMPATIBLE WITH RFC[1000]

Design Notes

In the middle of the coding sequence there was an EcoRI site. Therefore we performed a site directed mutagenesis PCR with the following primers to erase the forbidden restriction site:

Primer 1: GATCGAATTCGCGGCCGCTTCTAGATAAGGAGGTCAAAAATGgccggcGATAAGAAATACTCAATAGGC

Primer 2: CATAATAAGGAATACGAAAAGTCAAG

Primer 3: CATAATAAGGAATACGAAAAGTCAAG

Primer 4: GATCTCTGCAGCGGCCGCTACTAGTATTAACCGGTGTCACCTCCTAGCTGACTCAAATC

dCas9 site directed mutagenesis

The primers used to adapt this BioBrick to the Freiburg RFC25 standard were the following ones:

Prefix: GAATTCGCGGCCGCTTCTAGATAAGGAGGTCAAAAATGgccggc

Suffix: accggttaaTACTAGTAGCGGCCGCTGCAG

Find more information in here

References

[1] Whinn KS, Kaur G, Lewis JS, et al. (2019) Nuclease dead Cas9 is a programmable roadblock for DNA replication. Sci Rep. Sep 16;9(1):13292